EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness

Jose N Nativi-Nicolau, Chafic Karam, Sami Khella, Mathew S Maurer

Heart Failure Reviews · 2022-05 · 27 (3) · 785-793

DOI: 10.1007/s10741-021-10080-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Heart Failure Reviews, online erschienen am 20.02.2021. Verfasst von Jose N Nativi-Nicolau und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USA. jose.nativi@hsc.utah.edu. Hauptthemen laut MEDLINE: Amyloid Neuropathies, Familial, Prealbumin. Die Arbeit wurde bisher 118-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Akcea Therapeutics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Amyloid transthyretin (ATTR) amyloidosis is a clinically heterogeneous and fatal disease that results from deposition of insoluble amyloid fibrils in various organs and tissues, causing progressive loss of function. The objective of this review is to increase awareness and diagnosis of ATTR amyloidosis by improving recognition of its overlapping conditions, misdiagnosis, and multiorgan presentation. Cardiac manifestations include heart failure, atrial fibrillation, intolerance to previously prescribed antihypertensives, sinus node dysfunction, and atrioventricular block, resulting in the need for permanent pacing. Neurologic manifestations include progressive sensorimotor neuropathy (e.g., pain, weakness) and autonomic dysfunction (e.g., erectile dysfunction, chronic diarrhea, orthostatic hypotension). Non-cardiac red flags often precede the diagnosis of ATTR amyloidosis and include musculoskeletal manifestations (e.g., carpal tunnel syndrome, lumbar spinal stenosis, spontaneous rupture of the distal tendon biceps, shoulder and knee surgery). Awareness and recognition of the constellation of symptoms, including cardiac, neurologic, and musculoskeletal manifestations, will help with early diagnosis of ATTR amyloidosis and faster access to therapies, thereby slowing the progression of this debilitating disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Neuropathies, FamilialPrealbuminAmyloidDiagnostic ErrorsHumansMale

Stichwörter der Autor:innen

ATTRvAmyloidosisCardiomyopathyTransthyretin amyloidosishATTR

Substanzen

AmyloidPrealbumin

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, USA. jose.nativi@hsc.utah.edu.
  • Department of Neurology, Oregon Health & Science University, Portland, OR, USA.
  • Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.
  • Department of Medicine, Columbia University, New York, NY, USA.

Förderung

  • Akcea Therapeutics

Zitieren

APA

Nativi-Nicolau, J. N., Karam, C., Khella, S., & Maurer, M. S. (2022). Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Failure Reviews, 27(3), 785-793. https://doi.org/10.1007/s10741-021-10080-2

Vancouver

Nativi-Nicolau JN, Karam C, Khella S, Maurer MS. Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Failure Reviews. 2022;27(3):785-793. doi:10.1007/s10741-021-10080-2

BibTeX
@article{NativiNicolau2022,
  author = {Nativi-Nicolau, Jose N and Karam, Chafic and Khella, Sami and Maurer, Mathew S},
  title = {Screening for ATTR amyloidosis in the clinic: overlapping disorders, misdiagnosis, and multiorgan awareness},
  journal = {Heart Failure Reviews},
  year = {2022},
  volume = {27},
  number = {3},
  pages = {785--793},
  doi = {10.1007/s10741-021-10080-2}
}
Kostenlos starten →